OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

Completed · Phase 1 · Has a placebo group

Conditions studied: Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement

In brief

The purpose of this study is to describe the safety and tolerability of two dose levels of OTO-201, placebo and sham when administered intra-operatively in pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.

Key facts

Study ID

NCT01755286

Run by

Otonomy, Inc.

People needed

83

Starts

2012-12-01

Expected to finish

2013-06-01

Last updated by the study team

2013-06-19

Who can join

Age: 1 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Call/Email Otonomy Central Contact for Trial Locations — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.